Therapeutic potential of the 2-alkyl and 2-alkylidene-19-nor-(20S)-modified analogs of 1α,25-dihydroxyvitamin D3

Journal of Steroid Biochemistry and Molecular Biology

Volumn 89-90, Issue , 2004, Pages 67-73

  DeLuca, Hector F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Bone synthesis; Non calcemic Vitamin D analog; Parathyroid suppression; Vitamin D analog; Vitamin D and bone

Indexed keywords

2 METHYLENE 19 NOR 1ALPHA HYDROXYHOMOPREGNACALCIFEROL; 2 METHYLENE 19 NOR 1ALPHA HYDROXYPREGNACALCIFEROL; 2 METHYLENE 19 NOR 1ALPHA,25 DIHYDROXYVITAMIN D3; 2 METHYLENE 19 NOR BISHOMO 1ALPHA HYDROXYPREGNACALCIFEROL; 2ALPHA METHYL 19 NOR 1ALPHA,25 DIHYDROXYVITAMIN D3; CALCITRIOL DERIVATIVE; CALCIUM; PARATHYROID HORMONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BIOSYNTHESIS; BONE DISEASE; BONE METABOLISM; CIRCULATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; RAT; STEREOCHEMISTRY;

BONE AND BONES; CALCITRIOL; OSTEOPOROSIS;

EID: 3042592377     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.03.104     Document Type: Conference Paper

References (21)

1. H.F. DeLuca, Historical overview, in: D. Feldman, F.H. Glorieux, J.W. Pike (Eds.), Vitamin D, Academic Press, San Diego, 1997, Chapter 1, pp. 3-11.
2. Jones G., Strugnell S.A., DeLuca H.F. Current understanding of the molecular actions of Vitamin D. Physiol. Rev. 78:1998;1193-1231
3. Slatopolsky E., Finch J., Brown A. New Vitamin D analogs. Kidney Int. Suppl. 85:2003;83-87
4. 2, suppresses PTH secretion in uremic rats in the absence of hypercalcemia. J. Am. Soc. Nephrol. 5(3):1994;888. (Abstract)
5. Maung H.M., Elangovan L., Frazao J.M., Bower J.D., Kelley B.J., Acchiardo S.R., Rodriguez H.J., Norris K.C., Sigala J.F., Rutkowski M., Robertson J.A., Goodman W.G., Levine B.S., Chesney R.W., Mazess R.B., Kyllo D.M., Douglass L.L., Bishop C.W., Coburn J.W. Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2) in dialysis patients with secondary hyperparathyroidism: a sequential comparison. Am. J. Kidney Dis. 37:2001;532-543
6. 3, in rats. J. Biochem. 115:1994;373-380
7. 3 with an oxygen atom in the side chain. Biochem. Int. 19:1989;1143-1149
8. 3. J. Nutr. Sci. Vitaminol. (Tokyo). 36:1990;21-31
9. Stabert B., Roed-Petersen J., Menne T. Efficacy of topical treatment in psoriasis with MC 903, a new Vitamin D analogue. Acta Derm. Venereol. (Stockh.). 69:1989;147-150
10. Calverley M.J. Synthesis of MC 904, a biologically active Vitamin D metabolite. Tetrahedron. 43:1987;4609-4619
11. Binderup L., Kragballe K. Origin of the use of calcipotriol in psoriasis treatment. Rev. Contemp. Pharmacother. 3:1992;401-409
12. A.J. Brown, E. Slatopolsky, Mechanisms for the selective actions of Vitamin D analogs, in: D. Feldman, F.H. Glorieux, J.W. Pike (Eds.), Vitamin D, Academic Press, San Diego, 1997, Chapter 59, pp. 995-1009.
13. G. Jones, Analog metabolism, in: D. Feldman, F.H. Glorieux, J.W. Pike (Eds.), Vitamin D, Academic Press, San Diego, 1997, Chapter 58, pp. 973-994.
14. 3, a novel Vitamin D-related compound with potential therapeutic activity. Tetrahedron Lett. 31:1990;1823-1824
15. 3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl and 2-methylene analogs. J. Med. Chem. 41:1998;4662-4674
16. 3: synthesis, conformational analysis, biological activities, and docking to the modeled rVDR ligand binding domain. J. Med. Chem. 45:2002;3366-3380
17. 3 selectively induces bone formation. Proc. Natl. Acad. Sci. U.S.A. 99:2002;13487-13491
18. Suda T., Ueno Y., Fujii K., Shinki T. Vitamin D and bone. J. Cell Biochem. 88:2003;259-266
19. T. Suda, N. Takahashi, Vitamin D and osteoclastogenesis, in: D. Feldman, F.H. Glorieux, J.W. Pike (Eds.), Vitamin D, Academic Press, San Diego, 1997, Chapter 21, pp. 329-340.
20. 3 (VD) markedly increases bone mass of ovariectomized (OVX) rats, ASBMR (2002) (Abstract).
21. 3 potently stimulates gene-specific DNA binding of the Vitamin D receptor in osteoblasts, J. Biol. Chem. 278 (2003) 31756-31765.